Skip to content

TAKEDA PHARMACEUTICAL CO LTD

TAK TKPHF

CIK 0001395064 · Pharmaceutical Preparations · NYSE, OTC

← back to feed
Revenue (TTM)
¥4.58T
+7.5% YoY Mar 2025
Net Income (TTM)
¥107.93B
−25.1% YoY Mar 2025
EPS Diluted (TTM)
¥67.23
−26.3% YoY Mar 2025
Gross Margin
65.5%
Mar 2025
Operating Margin
7.5%
Mar 2025
Net Margin
2.4%
Mar 2025
Free Cash Flow (TTM)
—
Mar 2025
Cash
¥385.11B
Mar 2025
Total Debt
¥324.63B
Mar 2025
Shares Outstanding
1.56B sh
Mar 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings